Oncology Today with Dr Neil Love
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
Latest episodes
Jul 30, 2024 • 1h 1min
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Dr. Matthew Gubens, a clinical investigator from UCSF specializing in immunotherapy, discusses pivotal 2023 breakthroughs in treating non-small cell lung cancer (NSCLC) without actionable mutations. He highlights the evolution of immunotherapy, addressing challenges like colitis linked to genetic risk. Gubens also explores the impact of circulating tumor DNA on treatment choices and patient advocacy in complex cases. The conversation covers the potential of new therapies, including bispecific antibodies and antibody-drug conjugates, reshaping lung cancer treatment.
Jul 30, 2024 • 24min
Optimizing the Identification of HER2-Low Breast Cancer
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 26, 2024 • 59min
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Dr Dana M Chase from the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses select 2023 data sets on the management of ovarian, endometrial and cervical cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 24, 2024 • 48min
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
Dr Jonathan W Goldman from UCLA Health in Santa Monica, California, summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 19, 2024 • 1h 6min
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 17, 2024 • 1h 2min
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
Dr Rana R McKay from Moores Cancer Center in La Jolla, California, and Prof Thomas Powles from Barts Cancer Institute in London, United Kingdom, discuss recent updates on available and novel treatment strategies for renal cell carcinoma, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 12, 2024 • 1h 3min
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
Dr Scott Kopetz from The University of Texas MD Anderson Cancer Center in Houston, and Dr John Strickler from Duke University in Durham, North Carolina, discuss recent updates on available and novel treatment strategies for colorectal cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 12, 2024 • 1h 1min
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 10, 2024 • 1h 4min
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
Dr Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Heather McArthur from UT Southwestern Medical Center in Dallas, Texas, summarize the evolution of biomarker-driven treatment approaches for triple-negative breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
Jul 1, 2024 • 1h
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
